Operating income before deduction of amortization: codiagnostics.com (CODX)
The projected EBITDA level demonstrates operational efficiency dynamics, where 0.00 serves as the base parameter value. Co-Diagnostics, Inc. (CODX) is scaling the deployment of PCR systems through B2B contracts with laboratories to capture market share. Growth is driven by home platforms and tropical disease tests. High liquidity and stable cash flow completely offset financial risks associated with the creation of new products.
Summary analytical data breakdowns for Co-Diagnostics (CODX)
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- balance sheet equity data:
- business debt structure and liquidity details:
Total Debt to Equity Ratio Co-Diagnostics, Inc.|CODX - Long-Term Debt to Equity|Current Liabilities to Capital Co-Diagnostics Inc|CODX - Company Total Debt|Debt to Net Assets Co-Diagnostics|CODX - Company Long-Term Debts|Company Short-Term Indebtedness Co-Diagnostics|Interim Coverage Ratio codiagnostics.com
- company profitability and valuation multiples indicators:
CODX - Net Profit|Projected Future Earnings Co-Diagnostics, Inc.|CODX - P/E Multiple|Forward Price to Earnings Multiple codiagnostics.com|CODX - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Co-Diagnostics|CODX - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Co-Diagnostics|CODX - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months codiagnostics.com|CODX - Net earnings per share growth this year|Projected earnings per share increase next year Co-Diagnostics, Inc.
Fundamental company valuation:CODX, CoDx
To minimize long-term capital risks, it is critical to monitor the slowing growth of real cash flow from operating activities, which this operational financial result clearly reflects. Since the success of Co-Diagnostics, Inc. (CODX) depends on the commercialization of developments and product cycles, analyzing the dynamics of profit before non-cash expenses allows for an assessment of business scaling efficiency and helps avoid purchasing the asset at its peak liquidity.
Who Co-Diagnostics, Inc. competes with
Agilent Corp (A) - Profit before interest, taxes and amortization|DGX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization illumina.com ILMN|EXAS: Operating profit EBITDA|RVTY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Bio-Rad Laboratories Inc|Anbio Corp (NNNN) - Operating income before deduction of amortization|Operating profit EBITDA SHC|Operating profit before deduction of amortization quidel.com QDEL|Profit before payment of interest, taxes and amortization OPKO Health OPK|CareDx Corp (CDNA) - Profit before interest, taxes and amortization|MRVI: Operating profit before deduction of amortization|Operating profit before depreciation charges Fulgent (FLGT)|LAB: Operating profit EBITDA|Operating profit before amortization CTKB|OSUR (OraSure) - Operating profit EBITDA|Exagen Diagnostics (XGN) - Operating income before deduction of amortization|Operating profit EBITDA MDXH|Operating profit EBITDA Lucid Diagnostics, Inc (LUCD)|Operating profit EBITDA PRE (Prenetics)|Operating profit before depreciation charges Insight Molecular Diagnostics, Inc.|TRIB - Profit before payment of interest, taxes and amortization|PRPH (ProPhase Labs Inc) - Operating profit before amortization|Ainos Corp (AIMD) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Heart Test Labs (HSCS)|Profit before payment of interest, taxes and amortization Biomerica, Inc.|Cardio Diagnostics Holdings, Inc. (CDIO) - Operating income before deduction of amortization|Operating profit before deduction of amortization ONCO (Onconetix)|Company profit before taxes, interest and amortization VRAX|Operating profit EBITDA BJDX (Bluejay)|Operating income before deduction of amortization Aspira Women's Health Inc (AWH)|Accelerate Diagnostics - Operating profit EBITDA|Centogene (CNTG) - Operating profit before deduction of amortization|enzo.com (ENZ) - Profit before payment of interest, taxes and amortization|FRES - Operating income before deduction of amortization|Operating profit before deduction of amortization GENE|ME: Income before deduction of interest, taxes and amortization|Operating profit EBITDA PMD
